...fun and games with cut and past here for BIOTRON
For more information on the recent announcement of SIGNIFICANT IMMUNOLOGICAL OUTCOMES in BIT225 HIV-1 CLINICAL TRIAL, please refer to BIT announcement on 28/9/18.
This is a highly speculative stock, with potential for massive gains or loss given that it has made a fairly large movement in the past few days. But with a market cap of under $100m, IMO IF this positive result progresses further and especially leading to commercial outcomes, we could be just at the tip of the iceberg. DYOR as the is merely an expression of opinion.
